Physicochemical Properties
| Molecular Formula | C8H15CL4N4ORUS |
| Molecular Weight | 458.177895784378 |
| Exact Mass | 458.873 |
| CAS # | 201653-76-1 |
| PubChem CID | 133082692 |
| Appearance | Pink to red solid powder |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 0 |
| Heavy Atom Count | 19 |
| Complexity | 81.2 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | [Ru+3].[Cl-].[Cl-].[Cl-].[Cl-].S(C)(C)=O.[NH+]1C=CNC=1.N1C=NC=C1 |
| InChi Key | RJZBTXZRLXLLKO-UHFFFAOYSA-K |
| InChi Code | InChI=1S/2C3H4N2.C2H6OS.4ClH.Ru/c2*1-2-5-3-4-1;1-4(2)3;;;;;/h2*1-3H,(H,4,5);1-2H3;4*1H;/q;;;;;;;+3/p-3 |
| Chemical Name | 1H-imidazole;1H-imidazol-3-ium;methylsulfinylmethane;ruthenium(3+);tetrachloride |
| Synonyms | ImH-trans-RuCl4(DMSO)-Im; NAMIA |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen. Clin Cancer Res. 2003 May;9(5):1898-905. [2]. Inhibition of adhesion, migration and of α5β1 integrin in the HCT-116 colorectal cancer cells treated with the ruthenium drug NAMI-A. J Inorg Biochem. 2016 Jul;160:225-35. |
Solubility Data
| Solubility (In Vitro) | H2O : ~8.28 mg/mL (~18.07 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 6.67 mg/mL (14.56 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication (<60°C).  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.1825 mL | 10.9127 mL | 21.8255 mL | |
| 5 mM | 0.4365 mL | 2.1825 mL | 4.3651 mL | |
| 10 mM | 0.2183 mL | 1.0913 mL | 2.1825 mL |